Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Chiron/Baxter collaboration for novel cell therapy product for leukemia

Jan. 31, 1997

Potent antitumor agents from Takeda

Jan. 31, 1997

SKB reports novel camptothecin analogues

Jan. 30, 1997

Angiogenesis inhibitor induces dormancy in tumors

Jan. 29, 1997

Licenses offered for antibodies for treatment or diagnosis of breast cancer

Jan. 29, 1997

Invention related to melanoma antigens available for licensing

Jan. 29, 1997

NIH seeks licensees for T-cell receptor technologies

Jan. 29, 1997

Water-soluble camptothecin analogue reported by SKB

Jan. 29, 1997

Clinical data on AccuSite published in peer-reviewed journals

Jan. 28, 1997

RPR discloses novel polypeptides for cancer

Jan. 28, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...